Cath Lab Digest - February 2008 - (Page 3)

CONSULTING EDITORS MORTON KERN, MD Clinical Editor, Cath Lab Digest Clinical Professor of Medicine Associate Chief Cardiology University of California Irvine • Orange, CA ROBERT J. BASILE, SR., RT(R) Hackettstown Regional Medical Center Hackettstown, NJ A Product, News and Clinical Update for the Cardiac Catheterization Laboratory Specialist Februar y 2008 vol.16 no.2 DOUGLAS S. BEINBORN, MA, RN Mayo Clinic • Rochester, MN 1 Bay Regional Medical Center Scott Fylling, RCIS, Cath Lab Manager, Willa Rousseau, BSN, Cath Lab Director, Bay City, Michigan. Interviewed by Karen DiDonato, RN, MSN, Abbott Vascular, Redwood City, California. HEIDI N. BONNEAU, RN, MS Highlands Consulting, Inc. • San Jose, CA GEORGANN BRUSKI, RT(R), CRT, ARRT Beth Israel Deaconess Medical Center • Boston, MA 1 ENDEAVOR IV: A zotarolimus-eluting stent versus a paclitaxeleluting stent in a randomized clinical trial Cath Lab Digest talks with Martin B. Leon, MD, Professor of Medicine, Columbia University Medical Center, Founder and Chairman Emeritus of the Cardiovascular Research Foundation, New York, New York and Principal Investigator of the ENDEAVOR III and ENDEAVOR IV trials. JACK P. CHEN, MD, FACC, FSCAI Northside Cardiology P.C. • Atlanta, GA PATTI COBLENTZ, RN, BSN Provena Covenant Medical Center Urbana, IL 1 A 3D CT Vessel “Roadmap” Over Live Fluoroscopy for Chronic Total Occlusions Cath Lab Digest talks with Jeffrey W. Moses, MD, Director of the Center for Interventional Vascular Therapy, New York-Presbyterian Hospital/Columbia University Medical Center; Director, Cardiac Catheterization Lab, New YorkPresbyterian/Columbia University Medical Center; Professor of Medicine at Columbia University College of Physicians and Surgeons, New York, New York. 17 ANDREA E. DAVIS, BA, RCIS, FSICP George Washington University Hospital Washington, D.C. MICHELE DOUGHTY VOELTZ, MD Emory University School of Medicine Atlanta, Georgia 28 An Evaluation of Cath Lab Turnaround Time Rose Czarnecki, RN, BSN, MPM, Senior Cardiovascular Consultant, Health Care Visions, Ltd., Pittsburgh, Pennsylvania KENNETH A. GORSKI RN, RCIS, FSICP Sones Cardiac Catheterization Labs Cleveland Clinic Foundation • Cleveland, OH 31 COMMENTARY: An Evaluation of Cath Lab Turnaround Time Annie Ruppert, RN, BSN, Sharp Memorial Hospital, San Diego, California TODD GINAPP, EMT-P, RCIS, FSICP Memorial Hermann Southeast Houston, Texas 32 STEMI INTERVENTIONS 26 STEVE GRESSMIRE, RT(R)(CV) ARRT, AAMA Mississippi This month, we share excerpts from Dr. Mehta’s upcoming Textbook of STEMI Interventions: MARSHA HOLTON, RN, BS, CCRN, RCIS Cardiovascular Orientation Programs Indian Head, MD Excerpts from Chapter 19. STEMI Interventions – Future Perspectives Sameer Mehta, MD, FACC, MBA, Course Director – Lumen (Vascular Interventions Symposium), Miami, Florida GERALD LAGASSE, RCIS Borgess Medical Center • Kalamazoo, MI 40 MICHAEL LIM, MD St. Louis Health Sciences Center St. Louis, MO DRUG-ELUTING STENT SOLUTIONS: The Potential Clinical Utility of Intravascular Ultrasound Guidance in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents This monthly column in Cath Lab Digest reviews important points of distinction in drug-eluting stents, from characteristics to techniques, to provide valuable and relevant information about this technology. This month’s column is authored by Dr. Lowell Satler, Director of Interventional Cardiology at the Washington Hospital Center in Washington, D.C. TOM MALONEY, MS, RCIS Memorial Regional Medical Center Richmond, VA 50 DEPARTMENTS 4 54 56 58 60 62 64 Clinical Editor’s Corner Volunteer Survey SICP* Section Meetings Calendar What Do You Think? CEU Education Center Clinical & Industry News 69 Classifieds 74 Advertisers Index *Society of Invasive Cardiovascular Professionals Copyright© 2008 by HMP COMMUNICATIONS, All rights reserved. Opinions expressed by authors are their own and not necessarily those of their institution or HMP COMMUNICATIONS, the editorial staff, or any member of the editorial advisory board. JASON MONEY, RN, RCIS Elkins, AR 62 44 SICP: The Ten-Minute Interview with…Debbie Charlton, RN Director of Cardiology Services, Mobile Infirmary Medical Center, Mobile, Alabama YOUR PATH TO SUCCESS: CAREER ADVICE BHAWNA OBEROI, BSRS-CBRPA, RT(R)(M) Sherman Radiology Associates Sherman, TX The Cath Lab is a Business: Do You Have the Knowledge to Stay Afloat? James Burns, Vice President, Corazon, Inc., Pittsburgh, Pennsylvania TIM ROHRSCHNEIDER, BMSC, RT(R) Emory University Hospital, Children's Healthcare of Atlanta • Atlanta, Georgia 46 Incidence and Predictors of Vascular Complications after Invasive Coronary Procedures: A Prospective Analysis Neelima Penugonda, MD, Jennifer Jones, MD, J. Richard Spears, MD, Theodore Schreiber, MD, Wayne State University, Detroit, Michigan Reprinted with permission from Vascular Disease Management 2008;5(1):6–9. ANNIE RUPPERT, RN, BSN Sharp Memorial Hospital • San Diego, CA HABIB SAMADY, MD, FACC, FSCAI Emory University Hospital • Atlanta, Georgia 50 Ask the Clinical Instructor: A Q&A column for those new to the cath lab Questions are answered by: Todd Ginapp, EMT-P, RCIS, FSICP. Todd is the Cardiology Manager for Memorial Hermann Southeast in Houston, Texas. He also teaches an online RCIS Review course for Spokane Community College, in Spokane, Washington, and regularly presents with RCIS Review Courses. JACKSON L. THATCHER, MD, FACC The Park Nicollet Heart Center at Methodist Hospital, St. Louis Park, MN SANDY WATSON, RN, BN, NFESC Switzerland 43 Society of Invasive Cardiovascular Professionals (SICP) at Transcatheter Cardiovascular Therapeutics (TCT) 2007 Darren Powell, RCIS, FSICP, Program Director for Invasive Cardiovascular Technology, Spokane Community College, Spokane, WA; SICP education co-chair SICP: The CHUCK WILLIAMS, BS, RT(R)(CV)(CI), RCIS, FSICP Atlanta, GA

Table of Contents Feed for the Digital Edition of Cath Lab Digest - February 2008

Cath Lab Digest - February 2008 Bay Regional Medical Center ENDEAVOR IV: A Zotarolimus-Eluting Stent Versus a Paclitaxel-Eluting Stent in a Randomized Clinical Trial A 3D CT Vessel “Roadmap” Over Live Fluoroscopy for Chronic Total Occlusions Contents Clinical Editor’s Corner An Evaluation of Cath Lab Turnaround Time Commentary: An Evaluation of Cath Lab Turnaround Time Excerpts from Chapter 19. STEMI Interventions – Future Perspectives The Potential Clinical Utility of Intravascular Ultrasound Guidance in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents The Ten-Minute Interview with…Debbie Charlton, RN The Society of Invasive Cardiovascular Professionals (SICP) at Transcatheter Cardiovascular Therapeutics (TCT) 2007 The Cath Lab is a Business: Do You Have the Knowledge to Stay Afloat? Incidence and Predictors of Vascular Complications after Invasive Coronary Procedures: A Prospective Analysis Ask the Clinical Instructor: A Q&A Column for those New to the Cath Lab Volunteer Survey SICP* Section Meetings Calendar What Do You Think? CEU Education Center Clinical & Industry News Classifieds Advertisers Index

Cath Lab Digest - February 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.